Idexx Laboratories
IDXX
613 hedge funds and large institutions have $11.9B invested in Idexx Laboratories in 2017 Q4 according to their latest regulatory filings, with 79 funds opening new positions, 162 increasing their positions, 265 reducing their positions, and 36 closing their positions.
119% more first-time investments, than exits
New positions opened: 79 | Existing positions closed: 36
7% more funds holding
Funds holding: 573 → 613 (+40)
0% more funds holding in top 10
Funds holding in top 10: 15 → 15 (0)
7% less capital invested
Capital invested by funds: $12.8B → $11.9B (-$902M)
16.3% less ownership
Funds ownership: 103.58% → 87.28% (-16%)
39% less repeat investments, than reductions
Existing positions increased: 162 | Existing positions reduced: 265
49% less call options, than puts
Call options by funds: $16.5M | Put options by funds: $32.3M
Top Buyers
Top Sellers
| 1 |
Fundsmith LLP
London,
United Kingdom
|
-$2.22B |
| 2 |
CCI
Columbus Circle Investors
|
-$47M |
| 3 |
BlackRock
New York
|
-$41.2M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$36.9M |
| 5 |
JP Morgan Chase
New York
|
-$35.8M |
IDXX Hedge Fund Activity: Q4 2017 in Review
613 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q4 2017, worth a combined $11.9B — down 7.1% from $12.8B a quarter earlier.
Buyers outnumbered sellers: 79 funds opened new IDXX positions and 36 closed out — a net gain of 43 holders — while 162 added to existing stakes and 265 trimmed.
The largest buyer was William Blair Investment Management, adding an estimated $78.8M. The largest seller was Fundsmith LLP, cutting an estimated $2.22B.
- 613 institutional investors held Idexx Laboratories (IDXX) as of Q4 2017, up from 573 in Q3 2017.
- Funds reported $11.9B of Idexx Laboratories stock for Q4 2017, down 7.1% quarter-over-quarter.
- 79 funds opened new Idexx Laboratories positions in Q4 2017 and 36 closed out, a net change of +43 holders.
- The largest Idexx Laboratories buyer in Q4 2017 was William Blair Investment Management, an estimated $78.8M added.
- The largest Idexx Laboratories seller in Q4 2017 was Fundsmith LLP, an estimated $2.22B sold.
Based on aggregated 13F filings for Q4 2017.